Moors & Cabot’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Sell |
1,685
-126
| -7% | -$19.1K | 0.01% | 711 |
|
|
2025
Q1 | $273K | Sell |
1,811
-3
| -0.2% | -$452 | 0.01% | 672 |
|
|
2024
Q4 | $335K | Buy |
1,814
+9
| +0.5% | +$1.66K | 0.02% | 636 |
|
|
2024
Q3 | $356K | Sell |
1,805
-190
| -10% | -$37.4K | 0.02% | 608 |
|
|
2024
Q2 | $412K | Buy |
1,995
+18
| +0.9% | +$3.72K | 0.02% | 534 |
|
|
2024
Q1 | $536K | Sell |
1,977
-299
| -13% | -$81K | 0.03% | 473 |
|
|
2023
Q4 | $538K | Sell |
2,276
-5
| -0.2% | -$1.18K | 0.03% | 443 |
|
|
2023
Q3 | $447K | Sell |
2,281
-74
| -3% | -$14.5K | 0.03% | 469 |
|
|
2023
Q2 | $495K | Buy |
2,355
+108
| +5% | +$22.7K | 0.03% | 448 |
|
|
2023
Q1 | $453K | Buy |
2,247
+18
| +0.8% | +$3.63K | 0.03% | 463 |
|
|
2022
Q4 | $486K | Buy |
2,229
+90
| +4% | +$19.6K | 0.03% | 432 |
|
|
2022
Q3 | $421K | Buy |
2,139
+151
| +8% | +$29.7K | 0.03% | 452 |
|
|
2022
Q2 | $425K | Buy |
1,988
+100
| +5% | +$21.4K | 0.03% | 458 |
|
|
2022
Q1 | $536K | Sell |
1,888
-10
| -0.5% | -$2.84K | 0.03% | 448 |
|
|
2021
Q4 | $715K | Buy |
1,898
+100
| +6% | +$37.7K | 0.04% | 369 |
|
|
2021
Q3 | $743K | Buy |
+1,798
| New | +$743K | 0.05% | 344 |
|